Scleroderma – Understanding a Complex Autoimmune Disease
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Scleroderma – Understanding a Complex Autoimmune Disease
-
Letto da:
-
Di:
A proposito di questo titolo
Episode Description
Title: Scleroderma – Understanding a Complex Autoimmune Disease Series: Talking in the Woods – Science Behind the Script: From Lab to Life
Scleroderma is a rare autoimmune disease that hardens skin and can damage internal organs—but what causes it, and how is it treated? In this episode, host Christopher Wood breaks down the science behind scleroderma, from symptoms and diagnosis to cutting-edge therapies and clinical trials.
You’ll learn:
✔ Common symptoms like Raynaud’s phenomenon, lung fibrosis, and digestive issues
✔ Why genes like STAT4 and IRF5 matter—and how environment triggers disease
✔ How doctors diagnose scleroderma using ANA tests and autoantibody profiles
✔ Breakthrough treatments: stem cell transplants, biologics like Tocilizumab and Rituximab, and small molecules like Nintedanib
✔ The future of therapy: JAK inhibitors, TYK2 inhibitors, and precision medicine
✔ The science behind biologics vs small molecules—with real-world examples and a simple analogy: Biologics are custom-made keys; small molecules are universal tools
✔ Lifestyle tips to reduce flares and improve quality of life
Plus, hear Maria’s inspiring story—how a clinical trial gave her hope and improved her lung function by 20%.
- Resources Mentioned
- Scleroderma Foundation: https://www.scleroderma.org
- Clinical Trials: https://clinicaltrials.gov
- SCOT Trial Publication: New England Journal of Medicine
References
- Maria’s Story – Stem Cell Transplant Trial SCOT Trial: “Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.” Published in New England Journal of Medicine, 2018. Read the full article: https://www.nejm.org/doi/full/10.1056/NEJMoa1703327
- Future Therapies & Precision Medicine Varga J, et al. “Emerging Therapies for Systemic Sclerosis: Targeting Pathogenic Pathways.” Published in Nature Reviews Rheumatology, 2023. Read the full article: https://www.nature.com/articles/nrrheum.2023.XX
🎧 Listen now to understand the science, the stories, and the future of scleroderma treatment. Subscribe on Apple Podcasts, Spotify, YouTube, Pandora, or your favorite platform, and join us for Episode 5 on Myositis—coming soon!